PATH stock trades intraday at $11.74, with the market focused on UiPath Inc.’s upcoming earnings on 11 Mar 2026. Investors will watch EPS and revenue guidance closely after recent mixed price action: a +1.61% intraday move on volume of 31,673,024 shares. This earnings spotlight lays out the numbers that matter, valuation context, and a short-term trading framework ahead of the NYSE-listed company’s report.
PATH stock: earnings setup and near-term catalysts
UiPath (PATH) reports earnings on 11 Mar 2026, with consensus tracking EPS around $0.25 and revenue near $464.86 million. The quarter is the primary catalyst for intraday volatility and possible guidance updates. One clear driver will be margin commentary on subscription growth versus operating leverage, which investors have flagged as decisive for the stock’s direction.
Price action and technicals for PATH stock
PATH stock is trading at $11.74, up $0.19 or 1.61% today, within a daily range of $11.62–$12.00. The 50-day average sits at $13.69 and the 200-day average at $13.44, showing near-term underperformance versus those moving averages. Technical indicators show RSI 49.38 and ADX 36.51, indicating a defined trend and room for an earnings-driven breakout or breakdown.
Fundamentals and valuation: key ratios
UiPath reports trailing EPS of $0.42 and a TTM P/E of 28.23, with market capitalization roughly $6.34 billion. Price-to-sales sits near 4.05 and price-to-book near 3.30, while gross margin is 83.16%, reflecting software economics. The company has a strong current ratio of 2.54 and net debt to EBITDA is negative, highlighting healthy liquidity and low leverage.
Meyka AI grade, model forecast and price targets
Meyka AI rates PATH with a score out of 100: 76.32 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12‑month base price of $15.48, a monthly model of $8.16, and a quarterly target of $11.89.
Analyst consensus, risks and recent news for PATH stock
Street coverage shows 1 Buy, 10 Hold, consensus score ~3.00, and no uniform price-target range. Risks ahead of the print include weaker-than-expected subscription growth and guide-downs for FY26. Recent coverage highlights the upcoming earnings event and valuation comparisons; see Reuters and Nasdaq reporting for context source source.
Trading strategy and catalyst timeline
For intraday and short-term traders, watch implied volatility in options and pre-open volume into 11 Mar 2026. A conservative trade plan: scale into size after the print or hedge with short-dated puts if management signals slower license adoption. Longer-term investors should weigh growth metrics against a base price target and buy on confirmed revenue acceleration or margin expansion.
Final Thoughts
Key takeaways: PATH stock trades at $11.74 ahead of the 11 Mar 2026 earnings report, where investors will prioritize EPS, revenue growth, and subscription metrics. Meyka AI’s model projects a 12‑month base target of $15.48, implying an upside of 31.88% versus the current price; conservative and bull targets we model are $12.50 (near-term), $15.50 (base), and $18.00 (bull). Valuation shows P/E 28.23 and price-to-sales 4.05, which compares favorably to long-term growth yet leaves little margin for a negative guide. Our Meyka AI grade (B+, 76.32) reflects healthy fundamentals, sector positioning in Technology, and mixed near-term sentiment. Forecasts are model-based projections and not guarantees; monitor the earnings print, management comments, and sector moves for actionable signs before increasing exposure. For live updates and real-time context, view the UiPath stock page on Meyka AI at https://meyka.ai/stocks/PATH.
FAQs
When does UiPath report earnings and what should investors watch?
UiPath reports on 11 Mar 2026. Investors should watch EPS, revenue, subscription growth, renewal rates, and management guidance for FY26. These items will drive short-term moves in PATH stock.
What is Meyka AI’s forecast for PATH stock?
Meyka AI’s forecast model projects a 12‑month base price of $15.48, implying about 31.88% upside from the current $11.74. Forecasts are model-based and not guarantees.
How does UiPath’s valuation compare to peers?
UiPath trades at a TTM P/E near 28.23 and price-to-sales near 4.05, which sits in line with high-growth software peers but requires continued revenue expansion to justify multiples.
What are the main risks that could move PATH stock after earnings?
Key risks include weaker subscription adoption, disappointing renewal metrics, and cautious FY26 guidance. Slower enterprise spending could widen downside pressure on PATH stock post-earnings.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)